People · Operator
Named in public records as an officer, director or promoter · active 2009–2024 · Pharmaceuticals, Biotechnology, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Aclaris Therapeutics, Inc. | — | Pharmaceuticals | Series C | $192.5M | $611.8M | 2020 |
| Uptake Medical Corp | — | Biotechnology | Series C | $113.2M | $98.2M | 2011 |
| Agile Therapeutics Inc | — | Pharmaceuticals | Series B | $89.6M | $266.5M | 2012 |
| Sirion Holdings, Inc. | — | Pharmaceuticals | Series B | $30.2M | $941.4M | 2009 |
| Planet Biopharmaceuticals, Inc. | — | Other Health Care | Seed | $1.5M | $37.2M | 2010 |
Andrew Schiff at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Andrew Schiff on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Peter Barrett | 1 | 18 |
| Ketan Patel | 1 | 10 |
| Albert Cha | 1 | 9 |
| John Brooks | 1 | 8 |
| David Gordon | 1 | 8 |
| Scott Huennekens | 1 | 7 |
| Stephen Tullman | 1 | 7 |
| ANAND MEHRA | 1 | 7 |
| Eric Kim | 1 | 7 |
| BARRY BUTLER | 1 | 6 |
| Charles Cohen | 1 | 6 |
| Neal Walker | 1 | 5 |
| Anthony Maida | 1 | 5 |
| Maxine Gowen | 1 | 4 |
| Carl Simpson | 1 | 4 |
| Kevin Kinsella | 1 | 4 |
| Karen Hong | 1 | 4 |
| Scott Glenn | 1 | 4 |
| Michael Hoey | 1 | 4 |
| Todd Creech | 1 | 4 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.